Journal
RHEUMATOLOGY INTERNATIONAL
Volume 25, Issue 6, Pages 481-484Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00296-004-0463-z
Keywords
anakinra; fatigue; rheumatoid arthritis; treatment
Categories
Ask authors/readers for more resources
Fatigue occurs in many patients with rheumatoid arthritis (RA) and other chronic inflammatory diseases and may be defined as an overwhelming sense of tiredness, lack of energy, and feeling of exhaustion. It can be restrictive and severely disabling. We recently found more than 3/4 of systemic lupus erythematosus patients to be significantly affected by this phenomenon. We hypothesized that fatigue in patients with RA might be comparable to sickness behavior in animals possibly caused by disturbances in interleukin-1 beta signaling pathways and thus accessible to blockade by biologic agents. This study compared measures of disease behavior and fatigue symptoms in eight RA patients before and at three time points during treatment with daily administration of anakinra.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available